BevCanna Enterprises



Khiron Receives Approval To Renew Its Normal Course Issuer Bid

Khiron Announces Intention to Renew its Normal Course Issuer Bid

Khiron Registers its First Two Medical Cannabis Products in Peru, Available for Sale Nationwide

Khiron Reports Q2 Results, 47% QoQ Increase in Medical Cannabis Revenues Driven by Colombia and Germany

Khiron to Host Second Quarter 2021 Conference Call on August 23, 2021

Khiron Life Sciences Corp.: Invitation to the Q3 Virtual Investor Summit

Khiron Publishes Inaugural 2020 ESG Report, Demonstrating Commitment to Sustainability and Continued Market Leadership

Khiron Welcomes Dr. Eduardo Faveret as Medical Director for Brazil

Colombia Expands Distribution of Medical Cannabis to Pharmacies Nationwide and Opens Export Market for Dried Flower Medical Cannabis

Khiron Life Sciences Closes $12.3 Million Equity Financing

Khiron Life Sciences Announces Terms of Overnight Marketed Offering

Khiron Life Sciences Announces Proposed Offering of Securities

Khiron Announces Results of 2021 Annual General Meeting

Khiron successfully completes first medical cannabis sale in Brazil

Vicente Fox, Khiron Board Member and Former President of Mexico, Applauds Mexican Supreme Court's Advancement of Cannabis Laws

Khiron Accelerates Entry into Mexico, Awarded High-THC Extract Export Quotas for Mexico by the Government of Colombia

Khiron provides European management updates

Khiron Opens First Zerenia™ Clinic in Peru, Prescribing High and Low THC Medical Cannabis Products to Patients

Khiron receives its largest European medical cannabis shipment to date

Khiron Life Sciences Corp.: Invitation to the Benzinga Virtual Cannabis Capital Conference

Khiron Announces Upcoming Investor Events and Grant of Options and Restricted Share Units

Khiron Life Sciences Reports First Quarter 2021 Financial Results

Khiron Partners with Colombia Cancer League to Deliver 3,000 Medical Cannabis Patient Consultations

Khiron to Host First Quarter 2021 Conference Call on May 28, 2021

Khiron Life Sciences Corp.: Invitation to the Q2 Virtual Investor Summit

Khiron Comments on the Results of Project Twenty21 - UK´s Largest Observational Study into Medical Cannabis Products

Khiron to Present at Canaccord Genuity's Virtual Cannabis Conference

Khiron Life Sciences Reports 2020 Fiscal Year End Results and Provides Corporate Update

Khiron Receives Accreditation for UK Medical Cannabis Education and Partners with UK's Cellen Therapeutics to Improve Clinician Education

Khiron Expands Product Offering in UK and Increases Patient Access

Khiron Medical Cannabis Products Arrive in Germany for Immediate Prescription, Sale and Distribution

Khiron Updates Zerenia™ Expansion Program; Announces Plans to Open Three Additional Satellite Clinics in Colombia by End of Q2

Khiron Life Sciences Corp. To Present At The Q1 Virtual Investor Summit

Khiron Becomes First Colombian Medical Cannabis Company to Export Live Cannabis Clones to Europe

Khiron and Tecnologico de Monterrey of Mexico Launch First Internationally Accredited Medical Cannabis Diploma in Latin America

Khiron Life Sciences Corp.: Invitation to the Benzinga Virtual Cannabis Capital Conference

Khiron Announces Expansion of Small-Format Zerenia™ Clinics in Colombia Following Success of Initial Launch

Khiron Announces Grants of Restricted Share Units

Khiron Announces Live Webcast and Upcoming Investor Events